Cohen Joel L, Biesman Brian S, Dayan Steven H, DeLorenzi Claudio, Lambros Val S, Nestor Mark S, Sadick Neil, Sykes Jonathan
Dr Cohen is an Associate Clinical Professor in the Department of Dermatology at the University of Colorado, Boulder, and an Assistant Clinical Professor in the Department of Dermatology at the University of California Irvine. Dr Biesman is a Clinical Assistant Professor in the Departments of Ophthalmology and Otolaryngology and the Division of Dermatology at Vanderbilt University Medical Center, Nashville, TN. Dr Dayan is a Clinical Assistant Professor in the Department of Otolaryngology at the University of Illinois, Chicago. Dr DeLorenzi is a plastic surgeon in private practice in Kitchener, Ontario, Canada. Dr Lambros is a Clinical Professor of Plastic Surgery at the University of California Irvine. Dr Nestor is a Voluntary Associate Professor in the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine, FL. Dr Sadick is a Clinical Professor of Dermatology at Weill Cornell Medical College, New York, NY. Dr Sykes is a Professor and the Director of Facial Plastic Surgery in the Department of Otolaryngology at the UC Davis Health System of the University of California Davis, Sacramento.
Aesthet Surg J. 2015 Sep;35(7):844-9. doi: 10.1093/asj/sjv018. Epub 2015 May 10.
Injection-induced necrosis is a rare but dreaded consequence of soft tissue augmentation with filler agents. It usually occurs as a result of injection of filler directly into an artery, but can also result from compression or injury. We provide recommendations on the use of hyaluronidase when vascular compromise is suspected. Consensus recommendations were developed by thorough discussion and debate amongst the authors at a roundtable meeting on Wednesday June 18, 2014 in Las Vegas, NV as well as significant ongoing written and verbal communications amongst the authors in the months prior to journal submission. All authors are experienced tertiary care providers. A prompt diagnosis and immediate treatment with high doses of hyaluronidase (at least 200 U) are critically important. It is not felt necessary to do a skin test in cases of impending necrosis. Some experts recommend dilution with saline to increase dispersion or lidocaine to aid vasodilation. Additional hyaluronidase should be injected if improvement is not seen within 60 minutes. A warm compress also aids vasodilation, and massage has been shown to help. Some experts advocate the use of nitroglycerin paste, although this area is controversial. Introducing an oral aspirin regimen should help prevent further clot formation due to vascular compromise. In our experience, patients who are diagnosed promptly and treated within 24 hours will usually have the best outcomes.
注射所致坏死是软组织填充剂填充后罕见但可怕的后果。它通常是由于将填充剂直接注入动脉所致,但也可能由压迫或损伤引起。当怀疑有血管受损时,我们提供关于使用透明质酸酶的建议。共识性建议是作者们于2014年6月18日星期三在拉斯维加斯内华达州举行的圆桌会议上经过充分讨论和辩论,并在论文提交前几个月持续进行大量书面和口头交流后制定的。所有作者都是经验丰富的三级医疗服务提供者。迅速诊断并立即用高剂量透明质酸酶(至少200单位)治疗至关重要。在即将发生坏死的情况下,认为没有必要进行皮肤试验。一些专家建议用生理盐水稀释以增加扩散,或用利多卡因辅助血管扩张。如果在60分钟内未见改善,应注射额外的透明质酸酶。热敷也有助于血管扩张,并且已证明按摩有帮助。一些专家主张使用硝酸甘油膏,尽管这方面存在争议。采用口服阿司匹林方案应有助于预防因血管受损导致的进一步血栓形成。根据我们的经验,及时诊断并在24小时内接受治疗的患者通常会有最佳预后。